COVID-19 SARS-CoV-2 Ab, IgG

Specimen Plasma
Container Type Tall Green Top Tube

 

Stability 14 days
Turnaround Time 2-3 days
Methodology Chemiluminescent Sandwich Immunoassay

Test performed using Atellica IM SARS-CoV-2 IgG assay is intended for qualitative and semi-quantitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma. The current assay version has a measuring interval of 0.50 – 150.00 index as the semi-quantitation for the presence of IgG antibodies.

Reference Range Non-Reactive
Transport Temp Refrigerate 2°-8° C
Additional Info This test has been authoized by the FDA under the Emergency Use Authorization (EUA) for use by authorized laboratories. This antibody test result is not intended to be used as the sole basis for patient management decisions. Test results should be interpreted in conjunction with clinical observations, patient history, epidemiological information and other laboratory findings.
Price  $42.13
CPT Code 86769

 

Fact Sheet for Recipients (sCOVG)

Fact Sheet for Healthcare Providers (sCOVG)